Patricia M. Danzon

University of Pennsylvania - The Wharton School

Celia Moh Professor

Philadelphia, PA 19104-6367

United States

SCHOLARLY PAPERS

17

DOWNLOADS
Rank 17,171

SSRN RANKINGS

Top 17,171

in Total Papers Downloads

3,469

SSRN CITATIONS
Rank 6,179

SSRN RANKINGS

Top 6,179

in Total Papers Citations

33

CROSSREF CITATIONS

178

Scholarly Papers (17)

Mergers and Acquisitions in the Pharmaceutical and Biotech Industries

Number of pages: 43 Posted: 14 Nov 2003
Patricia M. Danzon, Andrew Joel Epstein and Sean Nicholson
University of Pennsylvania - The Wharton School, Yale University - School of Public Health and Cornell University - Department of Policy Analysis & Management (PAM)
Downloads 1,381 (16,335)
Citation 4

Abstract:

Loading...

Mergers and Acquisitions in the Pharmaceutical and Biotech Industries

NBER Working Paper No. w10536
Number of pages: 46 Posted: 17 Jun 2004 Last Revised: 17 Apr 2021
Patricia M. Danzon, Andrew Joel Epstein and Sean Nicholson
University of Pennsylvania - The Wharton School, Yale University - School of Public Health and Cornell University - Department of Policy Analysis & Management (PAM)
Downloads 301 (121,055)
Citation 4

Abstract:

Loading...

2.

Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents

Number of pages: 35 Posted: 16 Jul 2003
Patricia M. Danzon and Adrian Towse
University of Pennsylvania - The Wharton School and Office of Health Economics
Downloads 859 (33,389)
Citation 29

Abstract:

Loading...

differential pricing, pharmaceuticals, developing countries, parallel trade, Global Fund

3.

Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances

NBER Working Paper No. w9615
Number of pages: 40 Posted: 11 Apr 2003 Last Revised: 11 Apr 2021
Patricia M. Danzon, Sean Nicholson and Nuno Sousa Pereira
University of Pennsylvania - The Wharton School, Cornell University - Department of Policy Analysis & Management (PAM) and University of Pennsylvania - The Wharton School
Downloads 143 (243,034)
Citation 7

Abstract:

Loading...

4.

Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality

NBER Working Paper No. w9007
Number of pages: 47 Posted: 21 Jun 2002 Last Revised: 11 Feb 2021
Sean Nicholson, Patricia M. Danzon and Jeffrey McCullough
Cornell University - Department of Policy Analysis & Management (PAM), University of Pennsylvania - The Wharton School and University of Pennsylvania - The Wharton School
Downloads 134 (255,931)
Citation 3

Abstract:

Loading...

5.

Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand

NBER Working Paper No. w10007
Number of pages: 48 Posted: 05 Oct 2003 Last Revised: 07 May 2021
Patricia M. Danzon and Jonathan Ketcham
University of Pennsylvania - The Wharton School and Arizona State University (ASU) - Marketing Department
Downloads 119 (279,614)

Abstract:

Loading...

6.

The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s

NBER Working Paper No. w9874
Number of pages: 42 Posted: 08 Aug 2003 Last Revised: 04 Nov 2010
Patricia M. Danzon, Y. Richard Wang and Liang Leon Wang
University of Pennsylvania - The Wharton School, AstraZeneca Pharmaceuticals - Public Policy Department and University of Pennsylvania - Statistics Department
Downloads 118 (281,293)
Citation 5

Abstract:

Loading...

7.

Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?

Number of pages: 7 Posted: 25 Aug 2015
Martina Garau, Adrian Towse and Patricia M. Danzon
Office of Health Economics, Office of Health Economics and University of Pennsylvania - The Wharton School
Downloads 111 (293,592)
Citation 2

Abstract:

Loading...

8.

The Neglected Concern of Firm Size in Pharmaceutical Mergers

84 Antitrust Law Journal (forthcoming 2021)
Number of pages: 26 Posted: 18 Feb 2021 Last Revised: 23 Apr 2021
Patricia M. Danzon and Michael A. Carrier
University of Pennsylvania - The Wharton School and Rutgers Law School
Downloads 62 (415,804)

Abstract:

Loading...

pharmaceutical industry, mergers, acquisitions, antitrust, divestitures

9.

Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context

NBER Working Paper No. w18593
Number of pages: 23 Posted: 07 Dec 2012 Last Revised: 22 Apr 2021
Patricia M. Danzon, Adrian Towse and Jorge Mestre-Ferrandiz
University of Pennsylvania - The Wharton School, Office of Health Economics and Office of Health Economics
Downloads 50 (459,199)

Abstract:

Loading...

10.

Effects of Regulation on Drug Launch and Pricing in Interdependent Markets

NBER Working Paper No. w14041
Number of pages: 61 Posted: 02 Jun 2008 Last Revised: 03 Jun 2008
Patricia M. Danzon and Andrew Joel Epstein
University of Pennsylvania - The Wharton School and Yale University - School of Public Health
Downloads 48 (467,229)

Abstract:

Loading...

11.

Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future

The 13th Annual Herbert Lourie Memorial Lecture on Health Policy, 2002
Number of pages: 29 Posted: 25 Apr 2011
Patricia M. Danzon and Stephen Soumerai
University of Pennsylvania - The Wharton School and Harvard University - Department of Ambulatory Care and Prevention
Downloads 47 (471,375)

Abstract:

Loading...

12.

Vaccine Supply: Effects of Regulation and Competition

NBER Working Paper No. w17205
Number of pages: 46 Posted: 11 Jul 2011 Last Revised: 04 Jan 2021
Patricia M. Danzon and Nuno Sousa Pereira
University of Pennsylvania - The Wharton School and University of Pennsylvania - The Wharton School
Downloads 39 (506,376)

Abstract:

Loading...

13.

Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets

NBER Working Paper No. w17226
Number of pages: 44 Posted: 21 Jul 2011
Patricia M. Danzon and Michael Furukawa
University of Pennsylvania - The Wharton School and affiliation not provided to SSRN
Downloads 35 (525,571)

Abstract:

Loading...

14.

Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement

NBER Working Paper No. w17174
Number of pages: 33 Posted: 05 Jul 2011
Patricia M. Danzon, Andrew Mulcahy and Adrian Towse
University of Pennsylvania - The Wharton School, University of Pennsylvania - The Wharton School and Office of Health Economics
Downloads 22 (601,565)
Citation 2

Abstract:

Loading...

15.

Insurance and New Technology: From Hospital to Drugstore

Posted: 09 Oct 2001
Patricia M. Danzon and Mark V. Pauly
University of Pennsylvania - The Wharton School and University of Pennsylvania - Health Care Systems Department

Abstract:

Loading...

16.

Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance

Posted: 12 Sep 2000
Scott E. Harrington and Patricia M. Danzon
University of Pennsylvania - Wharton School and University of Pennsylvania - The Wharton School

Abstract:

Loading...

17.

Does Regulation Drive Out Competition in Pharmaceutical Markets?

Posted: 11 Jul 2000
Patricia M. Danzon and Li-Wei Chao
University of Pennsylvania - The Wharton School and Population Studies Center

Abstract:

Loading...